Significant Ownership of BIOS Fund I, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for BIOS Fund I, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ John Fucci - John Fucci/Attorney-in-Fact
- Manager location
- Fort Worth, TX
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow BIOS Fund I, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from BIOS Fund I, LP
Significant Ownership of BIOS Fund I, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ACTU | Actuate Therapeutics, Inc. | Common Stock, par value $0.000001 per share | 50% | $112,734,207 | +$1,733,259 | 10,267,232 | +1.6% | AARON G.L. FLETCHER | 27 Jun 2025 |
| RNTX | Rein Therapeutics, Inc. | Common Stock, $0.001 par value per share | 10% | $10,136,753 | 7,797,502 | BIOS CAPITAL MANAGEMENT, LP | 06 May 2026 |
Schedules 13D/G Reported by BIOS Fund I, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.